Company Search:
Advanced Search
Sponsored Links
Acorda Therapeutics, Inc. Company Snapshot
Acorda Therapeutics, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acorda Therapeutics with three other companies in this sector in UNITED STATES : Halozyme Therapeutics, Inc. (2019 sales of $195.99 million of which 36% was Royalties), Agenus Incorporation ($150.05 million of which 100% was Pharmacl preparations), and ANI Pharmaceuticals Inc ($206.55 million of which 100% was Pharmaceutical Products).

Sales Analysis. During the year ended December of 2019, sales at Acorda Therapeutics were $192.41 million. This is a sharp decrease of 59.2% versus 2018, when the company's sales were $471.43 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acorda Therapeutics, Inc.
  Stock Performance Chart for Acorda Therapeutics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): .67
(Figures in U.S. Dollars)
1 Week -9.1%   13 Weeks 23.8%  
4 Weeks -9.1%   52 Weeks -72.8%  
Acorda Therapeutics, Inc. Key Data:
  Ticker: ACOR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 192,408,000
(Year Ending Jan 2020).
Employees: 344
  Currency: U.S. Dollars Market Cap: 31,904,998
  Fiscal Yr Ends: December Shares Outstanding: 47,704,842
  Share Type: Common Closely Held Shares: 795,872
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.